Cerebral Venous Sinus Thrombosis Clinical Trial
Official title:
The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
Our previous clinical case observations showed that batroxobin combined with anticoagulation
therapy can improve the sinus recanalization rate in patients with CVST, shorten the hospital
stay, and increase the neurological score of patients. Its main mechanism is to inhibit
thrombosis after reducing fibrinogen, and to dissolve thrombus.
To further explore the safety of batroxobin combined with anticoagulation therapy for CVST,
an open-label, randomized controlled (1: 1), single-center, prospective study was used.
Further study on the safety and effectiveness of batroxobin combined with anticoagulation for
CVST.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03919305 -
Cerebral Venous Thrombosis Cohort Study in China Mainland
|
||
| Recruiting |
NCT03273179 -
Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales
|
N/A | |
| Recruiting |
NCT05291585 -
The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis.
|
N/A | |
| Recruiting |
NCT04966182 -
Application CT and MRI in Cerebral Venous Sinus Thrombosis
|
||
| Recruiting |
NCT05021198 -
The Norwegian Cerebral Venous Thrombosis Study
|
||
| Withdrawn |
NCT04580238 -
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
|
Phase 1 | |
| Completed |
NCT05448248 -
Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)
|